FR2901135B1 - Utilisation de modulateurs de la glycolyse comme agents diminuant la proliferation des keratinocytes - Google Patents

Utilisation de modulateurs de la glycolyse comme agents diminuant la proliferation des keratinocytes

Info

Publication number
FR2901135B1
FR2901135B1 FR0651880A FR0651880A FR2901135B1 FR 2901135 B1 FR2901135 B1 FR 2901135B1 FR 0651880 A FR0651880 A FR 0651880A FR 0651880 A FR0651880 A FR 0651880A FR 2901135 B1 FR2901135 B1 FR 2901135B1
Authority
FR
France
Prior art keywords
glycolysis
keratinocytes
modulators
proliferation
agents reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0651880A
Other languages
English (en)
Other versions
FR2901135A1 (fr
Inventor
Lionel Breton
Josserand Michelle Rathman
Potter Isabelle De
Louis Hue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0651880A priority Critical patent/FR2901135B1/fr
Publication of FR2901135A1 publication Critical patent/FR2901135A1/fr
Application granted granted Critical
Publication of FR2901135B1 publication Critical patent/FR2901135B1/fr
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0651880A 2006-05-22 2006-05-22 Utilisation de modulateurs de la glycolyse comme agents diminuant la proliferation des keratinocytes Active FR2901135B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0651880A FR2901135B1 (fr) 2006-05-22 2006-05-22 Utilisation de modulateurs de la glycolyse comme agents diminuant la proliferation des keratinocytes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0651880A FR2901135B1 (fr) 2006-05-22 2006-05-22 Utilisation de modulateurs de la glycolyse comme agents diminuant la proliferation des keratinocytes

Publications (2)

Publication Number Publication Date
FR2901135A1 FR2901135A1 (fr) 2007-11-23
FR2901135B1 true FR2901135B1 (fr) 2017-12-08

Family

ID=37571861

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0651880A Active FR2901135B1 (fr) 2006-05-22 2006-05-22 Utilisation de modulateurs de la glycolyse comme agents diminuant la proliferation des keratinocytes

Country Status (1)

Country Link
FR (1) FR2901135B1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108653736A (zh) * 2018-04-28 2018-10-16 中国人民解放军第二军医大学 M2型丙酮酸激酶作为药物靶点在制备防治银屑病的药物中的应用

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009093925A1 (fr) * 2008-01-23 2009-07-30 United Technologies Ut Ag Compositions cosmétiques comprenant du 5-amino-l-β-d-ribofuranosyl-lh-imidazole-4-carboxamide ou ses dérivés ou des sels de ceux-ci
FR3028857B1 (fr) * 2014-11-26 2017-01-06 Oreal C-glycosides derives d'acides amines
CN106309458A (zh) * 2016-07-28 2017-01-11 中南大学湘雅医院 2‑脱氧‑d‑葡萄糖及其在药学上可接受的盐在制备治疗银屑病药物方面的应用
CN113975255A (zh) * 2021-09-16 2022-01-28 中国人民解放军西部战区总医院 一种根皮素及其化学结构衍生物的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684747A (en) * 1984-12-20 1987-08-04 Yale University N,N'-bis(sulfonyl)hydrazines having antineoplastic activity
US4849563A (en) * 1986-01-21 1989-07-18 Yale University Novel 1-alkyl-1-arenesulfonyl-2-alkoxycarbonylsulfenylhydrazines having antineoplastic activity
CA2406871A1 (fr) * 2000-02-23 2001-08-30 Orentreich Foundation For The Advancement Of Science, Inc. Methodes et compositions de traitement de l'alopecie et d'autres troubles de l'appareil pilosebace
WO2006038111A1 (fr) * 2004-10-07 2006-04-13 Pfizer Products Inc. Derives de benzoimidazole utiles en tant qu'agents antiproliferatifs

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108653736A (zh) * 2018-04-28 2018-10-16 中国人民解放军第二军医大学 M2型丙酮酸激酶作为药物靶点在制备防治银屑病的药物中的应用

Also Published As

Publication number Publication date
FR2901135A1 (fr) 2007-11-23

Similar Documents

Publication Publication Date Title
ZA201001157B (en) Sulfonamides as trpm8 modulators
EP2178460A4 (fr) Greffes de cartilage
EP2200550A4 (fr) Formulations topiques de glycopyrrolate
EP2361224A4 (fr) Utilisation de déchets de dessalement
PT2173944T (pt) Composição de carga
EP2140877A4 (fr) Nouvelle utilisation de coccidies
EP2276339A4 (fr) Composition antimicrobienne et utilisation
EP2171096A4 (fr) Polymorphismes de carboxylestérase-1 etleurs méthodes d'utilisation
EP2099503A4 (fr) Bandage pour brûlures
ATE519836T1 (de) Flüssige weissgraderhaltungszusammensetzung
BRPI0910605A2 (pt) Composição com sensação de aquecimento
EP2438713A4 (fr) Détermination d'utilisation de serveur
BRPI0813230A2 (pt) Moduladores de calicreína 7
BRPI0716458A2 (pt) Composição de vulcanizado
EP1984325A4 (fr) Analogues de sulfonanilides comme modulateurs sélectifs des aromatases
EP2229933A4 (fr) Composition cosmétique capillaire
EP2051987A4 (fr) Utilisation de cd83 dans des polythérapies
EP2349266A4 (fr) Composés contenant du sulfamide et leurs utilisations
EP2269612A4 (fr) Préparation de gouttes ophtalmiques et utilisation
BRPI0815473A2 (pt) Composições estruturadas de sabão
EP2262365A4 (fr) Utilisation de -thio-2'-désoxynucléosides comme agents anti-orthopoxvirus
BRPI0918579A2 (pt) composição de gel tensoativa
BRPI0816154A2 (pt) Moduladores canabinóides de 5-vinilfenil-1-fenil-pirazol substituídos
EP2184063A4 (fr) Utilisation de léonurine et compositions
FR2899103B1 (fr) Utilisation cosmetique de d-ribose

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20